Max-Bio Biosciences Private Limited
About Max-Bio Biosciences Private Limited
Data last updated:
Max-Bio Biosciences Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2012PTC033839. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Indian Biomax Private Limited and Biomax Biosciences Private Limited. It is led by directors including Jatin Kumar and Rakesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at T – 4 Third Floor Centra Mall Ind. Area, Phase – 1 Chandigarh, Chandigarh, India – 160002.
As per the financials filed for FY 2023, the company reported a revenue of ₹22.97 Lakh. For the same year it recorded a net profit of ₹4,764 (net margin 0.2%) and EBITDA of ₹9.5 Lakh (EBITDA margin 41.4%). Revenue has declined at a compounded annual rate (CAGR) of 28% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Name history
Max-Bio Biosciences has undergone 2 name changes throughout its history. The company was previously known as Indian Biomax Private Limited, and Biomax Biosciences Private Limited. The current legal name is Max-Bio Biosciences Private Limited.
| Company Name | Status |
|---|---|
| Max-Bio Biosciences Private Limited | Current |
| Indian Biomax Private Limited | Previous |
| Biomax Biosciences Private Limited | Previous |
Contact details
Max-Bio Biosciences Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressT – 4 Third Floor Centra Mall Ind. Area, Phase – 1 Chandigarh, Chandigarh, India – 160002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Max-Bio Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Max-Bio Biosciences is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
Financials of Max-Bio Biosciences Private Limited
FY 2023 filings availableMax-Bio Biosciences Private Limited reported revenue of ₹22.97 Lakh for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 28% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.5 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4,764 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 41.4% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Max-Bio Biosciences Private Limited, buy the company report.
Board of directors of Max-Bio Biosciences Private Limited
Max-Bio Biosciences has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jatin Kumar Also directs: Rockbase Real Estate Projects Limited | Director | 10 Aug 2022 | 4 Years 2 Months | Current |
| Rakesh Kumar | Director | 02 Aug 2024 | 2 Years 2 Months | Current |
| Surinder Kumar Kalra Also directs: Rockbase Real Estate Projects Limited, Raconteur Global Resources Limited, Trustfield Project and Infra Limited and 2 more | Director | 19 Sep 2024 | 2 Years 1 Months | Current |
Auditor
Max-Bio Biosciences Private Limited is audited by VIKAS SANJIV & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIKAS SANJIV & ASSOCIATES | FY 2022 | 018361N |
Shareholding
The shareholding of Max-Bio Biosciences Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Max-Bio Biosciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Max-Bio Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Max-Bio Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Max-Bio Biosciences has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Max-Bio Biosciences Private Limited, buy the company report.
Recent activity
Max-Bio Biosciences Private Limited has 8 board changes on record since 2022: 3 appointments and 5 cessations. The latest: Surinder Kumar Kalra was appointed as Director on 19 Sep 2024.
Frequently asked questions
Max-Bio Biosciences is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 June 2012 (14+ years old) and is registered under CIN U24232CH2012PTC033839.
Max-Bio Biosciences has 3 current directors:
- Jatin Kumar - Director
- Rakesh Kumar - Director
- Surinder Kumar Kalra - Director
The latest financial statements of Max-Bio Biosciences on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
No. Max-Bio Biosciences has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Max-Bio Biosciences is U24232CH2012PTC033839. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Max-Bio Biosciences was incorporated on 04 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chandigarh.
Surinder Kumar Kalra was appointed as Director on 19 Sep 2024. Rakesh Kumar was appointed as Director on 02 Aug 2024. Abhishek Kumar ceased to be Additional Director on 29 Sep 2022. Max-Bio Biosciences has 8 board changes on record in total.
The registered office of Max-Bio Biosciences is at T – 4 Third Floor Centra Mall Ind. Area, Phase – 1 Chandigarh, Chandigarh, India – 160002.
Max-Bio Biosciences operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Max-Bio Biosciences is compliant as of 15 July 2026. The company is actively filing with the Registrar of Companies.